Abstract
A study published in this issue of Heart explores the associations between plasma osteoprotegerin (OPG) collected within 48 h of the onset of symptoms of a non-ST elevation acute coronary syndrome (NSTE-ACS) and 30 day and 1 year incidence of cardiovascular death.1 A strong association was observed between OPG and cardiovascular mortality, and baseline OPG was also an independent predictor of new or worsening heart failure (HF).
| Original language | English |
|---|---|
| Pages (from-to) | 762-763 |
| Number of pages | 2 |
| Journal | Heart (British Cardiac Society) |
| Volume | 98 |
| DOIs | |
| Publication status | Published - 2012 |
Keywords
- Acetanilides
- Acute Coronary Syndrome
- Electrocardiography
- Female
- Humans
- Male
- Osteoprotegerin
- Piperazines
Fingerprint
Dive into the research topics of 'Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver